XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jul. 02, 2023
Jul. 03, 2022
Operating activities:    
Net income $ 605,034 $ 356,174
Income from discontinued operations, net of income taxes (521,567) (10,503)
Income from continuing operations 83,467 345,671
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:    
Restructuring and other costs, net 5,104 12,669
Depreciation and amortization 217,938 218,030
Gain (Loss) on Extinguishment of Debt (3,345) 488
Stock-based compensation 23,526 29,665
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 1,085 1,363
Amortization of deferred debt financing costs and accretion of discounts 3,818 3,852
Change in fair value of financial securities (745) 9,215
Amortization of acquired inventory revaluation 0 33,724
Unrealized foreign exchange loss (23,679) 0
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:    
Accounts receivable, net (10,216) 80,334
Inventories (26,775) (31,794)
Accounts payable (49,225) (9,661)
Increase (Decrease) in Accrued Expenses and Other (240,285) (270,206)
Net cash provided by operating activities of continuing operations 28,026 423,350
Net cash used in operating activities of discontinued operations (99,882) (42,650)
Net cash (used in) provided by operating activities (71,856) 380,700
Investing activities:    
Capital expenditures (34,895) (46,472)
Purchases of Investments (5,000) (22,250)
Purchases of marketable securities (831,219) 0
Proceeds from marketable securities 100,000 0
Proceeds from Divestiture of Businesses 0 1,054
Cash paid for acquisitions, net of cash acquired (686) (5,635)
Net cash used in investing activities of continuing operations (771,800) (73,303)
Net cash provided by (used in) investing activities of discontinued operations 2,065,261 (11,358)
Net cash provided by (used in) investing activities 1,293,461 (84,661)
Financing activities:    
Payments of borrowings 0 220,000
Proceeds from borrowings 0 220,000
Repayments of Term Loan 0 (450,000)
Repayments of Senior Debt (50,835) 0
Payments of debt financing costs (15) 0
Settlement of cash flow hedges 0 (762)
Net payments on other credit facilities 7,231 (825)
Payments for acquisition-related contingent consideration (10,117) (5)
Proceeds from issuance of common stock under stock plans 3,215 5,841
Purchases of common stock (273,299) (56,048)
Dividends paid (17,638) (17,667)
Net cash used in financing activities (341,458) (519,466)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (17,571) (33,977)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent 862,576 (257,404)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period 470,746 619,337
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period 1,333,322 361,933
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 1,331,903 345,861
Restricted Cash, Current 1,062 1,073
Restricted Cash, Noncurrent 357 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,333,322 361,933
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents 0 14,999
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]    
Non-cash consideration in sale of business $ 261,317 $ 0